Nanoparticle-mediated thermal therapy: Evolving strategies for prostate cancer therapy

References

• Horsman MR, Overgaard J. Can mild hyperthermia improve tumour oxygenation?. Int J Hyperthermia 1997; 13: 141–147
   PubMed Web of Science ®Google Scholar
• Harmon BV, Takano YS, Winterford CM, Gobe GC. The role of apoptosis in the response of cells and tumours to mild hyperthermia. Int J Radiat Biol 1991; 59: 489–501
   PubMed Web of Science ®Google Scholar
• Fuller KJ, Issels RD, Slosman DO, Guillet JG, Soussi T, Polla BS. Cancer and the heat shock response. Eur J Cancer 1994; 30A: 1884–1891
   PubMed Web of Science ®Google Scholar
• Servadio C, Leib Z. Local hyperthermia for prostate cancer. Urology 1991; 38: 307–309
   PubMed Web of Science ®Google Scholar
• Stawarz B, Zielinski H, Szmigielski S, Rappaport E, Debicki P, Petrovich Z. Transrectal hyperthermia as palliative treatment for advanced adenocarcinoma of prostate and studies of cell‐mediated immunity. Urology 1993; 41: 548–553
   PubMed Web of Science ®Google Scholar
• Zhang HG, Mehta K, Cohen P, Guha C. Hyperthermia on immune regulation: A temperature's story. Cancer Lett 2008; 271: 191–204
   PubMed Web of Science ®Google Scholar
• Roti Roti JL. Introduction: Radiosensitization by hyperthermia. Int J Hyperthermia 2004; 20: 109–114
   PubMed Web of Science ®Google Scholar
• Kampinga HH, Dikomey E. Hyperthermic radiosensitization: Mode of action and clinical relevance. Int J Radiat Biol 2001; 77: 399–408
   PubMed Web of Science ®Google Scholar
• vander Zee J. Heating the patient: A promising approach?. Ann Oncol 2002; 13: 1173–1184
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 33–56
   PubMed Web of Science ®Google Scholar
• Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995; 345: 540–543
   PubMed Web of Science ®Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005; 23: 3079–3085
   PubMed Web of Science ®Google Scholar
• Anscher MS, Samulski TV, Dodge R, Prosnitz LR, Dewhirst MW. Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997; 37: 1059–1065
   PubMed Web of Science ®Google Scholar
• Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, vander Zee J, van Putten WL, van Rhoon GC, van Dijk JD, Gonzalez Gonzalez D, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996; 35: 731–744
   PubMed Web of Science ®Google Scholar
• vander Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119–1125
   PubMed Web of Science ®Google Scholar
• Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/− hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998; 40: 287–295
   PubMed Web of Science ®Google Scholar
• Satoh T, Seilhan TM, Stauffer PR, Sneed PK, Fike JR. Interstitial helical coil microwave antenna for experimental brain hyperthermia. Neurosurgery 1988; 23: 564–569
   PubMed Web of Science ®Google Scholar
• Shimm DS, Hynynen KH, Anhalt DP, Roemer RB, Cassady JR. Scanned focussed ultrasound hyperthermia: Initial clinical results. Int J Radiat Oncol Biol Phys 1988; 15: 1203–1208
   PubMed Web of Science ®Google Scholar
• Sherar MD, Trachtenberg J, Davidson SR, Gertner MR. Interstitial microwave thermal therapy and its application to the treatment of recurrent prostate cancer. Int J Hyperthermia 2004; 20: 757–768
   PubMed Web of Science ®Google Scholar
• Sherar MD, Trachtenberg J, Davidson SR, McCann C, Yue CK, Haider MA, Gertner MR. Interstitial microwave thermal therapy for prostate cancer. J Endourol 2003; 17: 617–625
   PubMed Web of Science ®Google Scholar
• Baronzio G, Gramaglia A, Fiorentini G. Review. Current role and future perspectives of hyperthermia for prostate cancer treatment. In Vivo 2009; 23: 143–146
   PubMed Web of Science ®Google Scholar
• Mendecki J, Friedenthal E, Botstein C, Paglione R, Sterzer F. Microwave applicators for localized hyperthermia treatment of cancer of the prostate. Int J Radiat Oncol Biol Phys 1980; 6: 1583–1588
   PubMed Web of Science ®Google Scholar
• Yerushalmi A, Servadio C, Leib Z, Fishelovitz Y, Rokowsky E, Stein JA. Local hyperthermia for treatment of carcinoma of the prostate: A preliminary report. Prostate 1982; 3: 623–630
   PubMed Web of Science ®Google Scholar
• Algan O, Fosmire H, Hynynen K, Dalkin B, Cui H, Drach G, Stea B, Cassady JR. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Cancer 2000; 89: 399–403
   PubMed Web of Science ®Google Scholar
• Fosmire H, Hynynen K, Drach GW, Stea B, Swift P, Cassady JR. Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1993; 26: 253–259
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Kaplan ID, Hansen JL, Prokopios‐Davos S, Topulos GP, Wishnow K, Manola J, Bornstein BA, Hynynen K. Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile. Int J Hyperthermia 2005; 21: 649–656
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Kaplan ID, Svensson GK, Hynynen K, Hansen MS. Feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for treatment of prostate cancer. Int J Hyperthermia 2001; 17: 31–37
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Kaplan ID, Hansen JL, Prokopios-Davos S, Topulos GP, Wishnow K, Manola J, Bornstein BA, Hynynen K. Association of rectal toxicity with thermal dose parameters in treatment of locally advanced prostate cancer with radiation and hyperthermia. Int J Radiat Oncol Biol Phys 2002; 53: 913–918
   PubMed Web of Science ®Google Scholar
• Zargar Shoshtari MA, Mirzazadeh M, Banai M, Jamshidi M, Mehravaran K. Radiofrequency-induced thermotherapy in benign prostatic hyperplasia. Urol J 2006; 3: 44–48
   PubMedGoogle Scholar
• Bhowmick S, Swanlund DJ, Coad JE, Lulloff L, Hoey MF, Bischof JC. Evaluation of thermal therapy in a prostate cancer model using a wet electrode radiofrequency probe. J Endourol 2001; 15: 629–640
   PubMed Web of Science ®Google Scholar
• Dawkins GP, Harrison NW, Ansell W. Radiofrequency heat-treatment to the prostate for bladder outlet obstruction associated with benign prostatic hyperplasia: A 4-year outcome study. Br J Urol 1997; 79: 910–914
   PubMedGoogle Scholar
• Sofras F, Sakkas G, Kontothanassis D, Lyssiotis F, Tamvakis N. Transurethral thermotherapy in the management of benign prostatic hyperplasia. Int Urol Nephrol 1996; 28: 673–679
   PubMedGoogle Scholar
• Gillett MD, Gettman MT, Zincke H, Blute ML. Tissue ablation technologies for localized prostate cancer. Mayo Clin Proc 2004; 79: 1547–1555
   PubMed Web of Science ®Google Scholar
• Marberger M. Energy-based ablative therapy of prostate cancer: High-intensity focused ultrasound and cryoablation. Curr Opin Urol 2007; 17: 194–199
   PubMed Web of Science ®Google Scholar
• Prionas SD, Kapp DS, Goffinet DR, Ben-Yosef R, Fessenden P, Bagshaw MA. Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1994; 28: 151–162
   PubMed Web of Science ®Google Scholar
• Emami B, Scott C, Perez CA, Asbell S, Swift P, Grigsby P, Montesano A, Rubin P, Curran W, Delrowe J, et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group. Int J Radiat Oncol Biol Phys 1996; 34: 1097–1104
   PubMed Web of Science ®Google Scholar
• Lancaster C, Toi A, Trachtenberg J. Interstitial microwave thermoablation for localized prostate cancer. Urology 1999; 53: 828–831
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Sim DA, Sapareto S, Connor WG. Importance of minimum tumor temperature in determining early and long-term responses of spontaneous canine and feline tumors to heat and radiation. Cancer Res 1984; 44: 43–50
   PubMed Web of Science ®Google Scholar
• Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10: 787–800
   PubMed Web of Science ®Google Scholar
• Thrall DE, LaRue SM, Yu D, Samulski T, Sanders L, Case B, Rosner G, Azuma C, Poulson J, Pruitt AF, et al. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res 2005; 11: 5206–5014
   PubMed Web of Science ®Google Scholar
• Oleson JR, Samulski TV, Leopold KA, Clegg ST, Dewhirst MW, Dodge RK, George SL. Sensitivity of hyperthermia trial outcomes to temperature and time: Implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 1993; 25: 289–297
   PubMed Web of Science ®Google Scholar
• Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V, Felix R, Wust P. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 2005; 181: 35–41
   PubMed Web of Science ®Google Scholar
• Moros EG, Corry PM, Orton CG. Thermoradiotherapy is underutilized for the treatment of cancer. Med Phys 2007; 34: 1–4
   PubMed Web of Science ®Google Scholar
• Brezovich IA, Meredith RF. Practical aspects of ferromagnetic thermoseed hyperthermia. Radiol Clin North Am 1989; 27: 589–602
   PubMed Web of Science ®Google Scholar
• Meredith RF, Brezovich IA, Weppelmann B, Henderson RA, Brawner WR, Jr, Kwapien RP, Bartolucci AA, Salter MM. Ferromagnetic thermoseeds: Suitable for an afterloading interstitial implant. Int J Radiat Oncol Biol Phys 1989; 17: 1341–1346
   PubMed Web of Science ®Google Scholar
• Partington BP, Steeves RA, Su SL, Paliwal BR, Dubielzig RR, Wilson JW, Brezovich IA. Temperature distributions, microangiographic and histopathologic correlations in normal tissue heated by ferromagnetic needles. Int J Hyperthermia 1989; 5: 319–327
   PubMed Web of Science ®Google Scholar
• Sharma R, Chen CJ. Newer nanoparticles in hyperthermia treatment and thermometry. Journal of Nanoparticle Research 2009; 11: 671–689
   Web of Science ®Google Scholar
• Naruse S, Higuchi T, Horikawa Y, Tanaka C, Nakamura K, Hirakawa K. Radiofrequency hyperthermia with successive monitoring of its effects on tumors using NMR spectroscopy. Proc Natl Acad Sci U S A 1986; 83: 8343–8347
   PubMed Web of Science ®Google Scholar
• Higby GJ. Gold in medicine: Review of its use in the west before 1900. Gold Bull 1982; 15: 130–140
   PubMedGoogle Scholar
• Parish RV. Biologically-active gold(III) complexes. Met Based Drugs 1999; 6: 271–276
   PubMedGoogle Scholar
• Abrams MJ, Murrer BA. Metal compounds in therapy and diagnosis. Science 1993; 261: 725–730
   PubMed Web of Science ®Google Scholar
• Daniel MC, Astruc D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 2004; 104: 293–346
   PubMed Web of Science ®Google Scholar
• Hulander M, Hong J, Andersson M, Gerven F, Ohrlander M, Tengvall P, Elwing H. Blood interactions with noble metals: Coagulation and immune complement activation. ACS Appl Materials Interfaces 2009; 1: 1053–1062
   PubMed Web of Science ®Google Scholar
• Oldenburg SJ, Jackson JB, Westcott SL, Halas NJ. Infrared extinction properties of gold nanoshells. Appl Phys Lett 1999; 75: 2897–2899
   Web of Science ®Google Scholar
• Jain PK, Lee KS, El‐Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: Applications in biological imaging and biomedicine. J Phys Chem B 2006; 110: 7238–7248
   PubMed Web of Science ®Google Scholar
• Oldenburg SJ, Averitt RD, Westcott SL, Halas NJ. Nanoengineering of optical resonances. Chem Phys Lett 1998; 288: 243–247
   Web of Science ®Google Scholar
• McDonald DM, Choyke PL. Imaging of angiogenesis: From microscope to clinic. Nat Med 2003; 9: 713–725
   PubMed Web of Science ®Google Scholar
• Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 2003; 163: 1801–1815
   PubMed Web of Science ®Google Scholar
• Jain RK. Transport of molecules, particles, and cells in solid tumors. Annu Rev Biomed Eng 1999; 1: 241–263
   PubMed Web of Science ®Google Scholar
• Han S, Lin J, Zhou F, Vellanoweth RL. Oligonucleotide-capped gold nanoparticles for improved atomic force microscopic imaging and enhanced selectivity in polynucleotide detection. Biochem Biophys Res Commun 2000; 279: 265–269
   PubMed Web of Science ®Google Scholar
• Lowery AR, Gobin AM, Day ES, Halas NJ, West JL. Immunonanoshells for targeted photothermal ablation of tumor cells. Int J Nanomedicine 2006; 1: 149–154
   PubMed Web of Science ®Google Scholar
• Loo C, Lowery A, Halas N, West J, Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 2005; 5: 709–711
   PubMed Web of Science ®Google Scholar
• Khan MK, Minc LD, Nigavekar SS, Kariapper MS, Nair BM, Schipper M, Cook AC, Lesniak WG, Balogh LP. Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy. Nanomedicine 2008; 4: 57–69
   PubMed Web of Science ®Google Scholar
• Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL. Nanoshell‐mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 2003; 100: 13549–13554
   PubMed Web of Science ®Google Scholar
• O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 2004; 209: 171–176
   PubMed Web of Science ®Google Scholar
• Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006; 128: 2115–2120
   PubMed Web of Science ®Google Scholar
• Hu M, Chen J, Li ZY, Au L, Hartland GV, Li X, Marquez M, Xia Y. Gold nanostructures: Engineering their plasmonic properties for biomedical applications. Chem Soc Rev 2006; 35: 1084–1094
   PubMed Web of Science ®Google Scholar
• Huff TB, Tong L, Zhao Y, Hansen MN, Cheng JX, Wei A. Hyperthermic effects of gold nanorods on tumor cells. Nanomed 2007; 2: 125–132
   PubMed Web of Science ®Google Scholar
• von Maltzahn G, Park JH, Agrawal A, Bandaru NK, Das SK, Sailor MJ, Bhatia SN. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 2009; 69: 3892–3900
   PubMed Web of Science ®Google Scholar
• Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H, Pushpanketh S, McDonald JF, El-Sayed MA. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 2008; 269: 57–66
   PubMed Web of Science ®Google Scholar
• Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 2008; 23: 217–228
   PubMed Web of Science ®Google Scholar
• Skrabalak SE, Au L, Lu X, Li X, Xia Y. Gold nanocages for cancer detection and treatment. Nanomed 2007; 2: 657–668
   PubMed Web of Science ®Google Scholar
• Wu X, Ming T, Wang X, Wang P, Wang J, Chen J. High-photoluminescence-yield gold nanocubes: For cell imaging and photothermal therapy. ACS Nano 2010;4:113–120.
   Google Scholar
• Schwartz JA, Shetty AM, Price RE, Stafford RJ, Wang JC, Uthamanthil RK, Pham K, McNichols RJ, Coleman CL, Payne JD. Feasibility study of particle‐assisted laser ablation of brain tumors in orthotopic canine model. Cancer Res 2009; 69: 1659–1667
   PubMed Web of Science ®Google Scholar
• Cheng FY, Chen CT, Yeh CS. Comparative efficiencies of photothermal destruction of malignant cells using antibody-coated silica/Au nanoshells, hollow Au/Ag nanospheres and Au nanorods. Nanotechnology 2009; 20: 425104
   PubMed Web of Science ®Google Scholar
• Kawano T, Niidome Y, Mori T, Katayama Y, Niidome T. PNIPAM gel-coated gold nanorods for targeted delivery responding to a near-infrared laser. Bioconjug Chem 2009; 20: 209–212
   PubMed Web of Science ®Google Scholar
• Huang YF, Sefah K, Bamrungsap S, Chang HT, Tan W. Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods. Langmuir 2008; 24: 11860–11865
   PubMed Web of Science ®Google Scholar
• Liu SY, Liang ZS, Gao F, Luo SF, Lu GQ. In vitro photothermal study of gold nanoshells functionalized with small targeting peptides to liver cancer cells. J Mater Sci Mater Med 2010;21:665–674.
   Google Scholar
• Bernardi RJ, Lowery AR, Thompson PA, Blaney SM, West JL. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: An in vitro evaluation using human cell lines. J Neurooncol 2008; 86: 165–172
   PubMed Web of Science ®Google Scholar
• Ma LL, Feldman MD, Tam JM, Paranjape AS, Cheruku KK, Larson TA, Tam JO, Ingram DR, Paramita V, Villard JW, et al. Small multifunctional nanoclusters (nanoroses) for targeted cellular imaging and therapy. ACS Nano 2009; 3: 2686–2696
   PubMed Web of Science ®Google Scholar
• Sokolov K, Follen M, Aaron J, Pavlova I, Malpica A, Lotan R, Richards-Kortum R. Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res 2003; 63: 1999–2004
   PubMed Web of Science ®Google Scholar
• Kumar S, Aaron J, Sokolov K. Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat Protoc 2008; 3: 314–320
   PubMed Web of Science ®Google Scholar
• Diagaradjane P, Shetty A, Wang JC, Elliott AM, Schwartz J, Shentu S, Park HC, Deorukhkar A, Stafford RJ, Cho SH, et al. Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: Characterizing an integrated antihypoxic and localized vascular disrupting targeting strategy. Nano Lett 2008; 8: 1492–1500
   PubMed Web of Science ®Google Scholar
• Stern JM, Stanfield J, Lotan Y, Park S, Hsieh JT, Cadeddu JA. Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. J Endourol 2007; 21: 939–943
   PubMed Web of Science ®Google Scholar
• Margulis V, Matsumoto ED, Lindberg G, Tunc L, Taylor G, Sagalowsky AI, Cadeddu JA. Acute histologic effects of temperature-based radiofrequency ablation on renal tumor pathologic interpretation. Urology 2004; 64: 660–663
   PubMed Web of Science ®Google Scholar
• Stern JM, Stanfield J, Kabbani W, Hsieh JT, Cadeddu JA. Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urol 2008; 179: 748–753
   PubMed Web of Science ®Google Scholar
• Gobin AM, Moon JJ, West JL. EphrinA I-targeted nanoshells for photothermal ablation of prostate cancer cells. Int J Nanomedicine 2008; 3: 351–358
   PubMed Web of Science ®Google Scholar
• Malugin A, Ghandehari H. Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: A comparative study of rods and spheres. J Appl Toxicol 2009;30:212–217.
   Google Scholar
• Moroz P, Jones SK, Gray BN. Magnetically mediated hyperthermia: Current status and future directions. Int J Hyperthermia 2002; 18: 267–284
   PubMed Web of Science ®Google Scholar
• Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993; 9: 51–68
   PubMed Web of Science ®Google Scholar
• Jordan A, Scholz R, Wust P, Fahling H, Krause J, Wlodarczyk W, Sander B, Vogl T, Felix R. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int J Hyperthermia 1997; 13: 587–605
   PubMed Web of Science ®Google Scholar
• Johannsen M, Jordan A, Scholz R, Koch M, Lein M, Deger S, Roigas J, Jung K, Loening S. Evaluation of magnetic fluid hyperthermia in a standard rat model of prostate cancer. J Endourol 2004; 18: 495–500
   PubMed Web of Science ®Google Scholar
• Johannsen M, Thiesen B, Jordan A, Taymoorian K, Gneveckow U, Waldofner N, Scholz R, Koch M, Lein M, Jung K, et al. Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate 2005; 64: 283–292
   PubMed Web of Science ®Google Scholar
• Johannsen M, Thiesen B, Gneveckow U, Taymoorian K, Waldofner N, Scholz R, Deger S, Jung K, Loening SA, Jordan A. Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer. Prostate 2006; 66: 97–104
   PubMed Web of Science ®Google Scholar
• Motoyama J, Yamashita N, Morino T, Tanaka M, Kobayashi T, Honda H. Hyperthermic treatment of DMBA-induced rat mammary cancer using magnetic nanoparticles. Biomagn Res Technol 2008; 6: 2
   PubMedGoogle Scholar
• Kawai N, Futakuchi M, Yoshida T, Ito A, Sato S, Naiki T, Honda H, Shirai T, Kohri K. Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone. Prostate 2008; 68: 784–792
   PubMed Web of Science ®Google Scholar
• Zheng LX, O'Connell MJ, Doorn SK, Liao XZ, Zhao YH, Akhadov EA, Hoffbauer MA, Roop BJ, Jia QX, Dye RC, et al. Ultralong single-wall carbon nanotubes. Nat Mater 2004; 3: 673–676
   PubMed Web of Science ®Google Scholar
• Kam NW, O'Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA 2005; 102: 11600–11605
   PubMed Web of Science ®Google Scholar
• O'Connell MJ, Bachilo SM, Huffman CB, Moore VC, Strano MS, Haroz EH, Rialon KL, Boul PJ, Noon WH, Kittrell C, et al. Band gap fluorescence from individual single-walled carbon nanotubes. Science 2002; 297: 593–596
   PubMed Web of Science ®Google Scholar
• Chakravarty P, Marches R, Zimmerman NS, Swafford AD, Bajaj P, Musselman IH, Pantano P, Draper RK, Vitetta ES. Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes. Proc Natl Acad Sci USA 2008; 105: 8697–8702
   PubMed Web of Science ®Google Scholar
• Wang CH, Huang YJ, Chang CW, Hsu WM, Peng CA. In vitro photothermal destruction of neuroblastoma cells using carbon nanotubes conjugated with GD2 monoclonal antibody. Nanotechnology 2009; 20: 315101
   PubMed Web of Science ®Google Scholar
• Torti SV, Byrne F, Whelan O, Levi N, Ucer B, Schmid M, Torti FM, Akman S, Liu J, Ajayan PM, et al. Thermal ablation therapeutics based on CN(x) multi-walled nanotubes. Int J Nanomedicine 2007; 2: 707–714
   PubMed Web of Science ®Google Scholar
• Biris AS, Boldor D, Palmer J, Monroe WT, Mahmood M, Dervishi E, Xu Y, Li Z, Galanzha EI, Zharov VP. Nanophotothermolysis of multiple scattered cancer cells with carbon nanotubes guided by time-resolved infrared thermal imaging. J Biomed Opt 2009; 14: 021007
   PubMed Web of Science ®Google Scholar
• Mahmood M, Karmakar A, Fejleh A, Mocan T, Iancu C, Mocan L, Iancu DT, Xu Y, Dervishi E, Li Z, et al. Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug. Nanomed 2009; 4: 883–893
   PubMed Web of Science ®Google Scholar
• Gannon CJ, Cherukuri P, Yakobson BI, Cognet L, Kanzius JS, Kittrell C, Weisman RB, Pasquali M, Schmidt HK, Smalley RE, et al. Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer 2007; 110: 2654–2665
   PubMed Web of Science ®Google Scholar
• Moon HK, Lee SH, Choi HC. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 2009; 3: 3707–3713
   PubMed Web of Science ®Google Scholar
• Burke A, Ding X, Singh R, Kraft RA, Levi-Polyachenko N, Rylander MN, Szot C, Buchanan C, Whitney J, Fisher J, et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc Natl Acad Sci USA 2009; 106: 12897–12902
   PubMed Web of Science ®Google Scholar
• Ghosh S, Dutta S, Gomes E, Carroll D, D'Agostino R, Jr, Olson J, Guthold M, Gmeiner WH. Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano 2009; 3: 2667–2573
   PubMed Web of Science ®Google Scholar
• Sayes CM, Liang F, Hudson JL, Mendez J, Guo W, Beach JM, Moore VC, Doyle CD, West JL, Billups WE, et al. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 2006; 161: 135–142
   PubMed Web of Science ®Google Scholar
• Magrez A, Kasas S, Salicio V, Pasquier N, Seo JW, Celio M, Catsicas S, Schwaller B, Forro L. Cellular toxicity of carbon-based nanomaterials. Nano Lett 2006; 6: 1121–1125
   PubMed Web of Science ®Google Scholar
• Wick P, Manser P, Limbach LK, Dettlaff-Weglikowska U, Krumeich F, Roth S, Stark WJ, Bruinink A. The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol Lett 2007; 168: 121–131
   PubMed Web of Science ®Google Scholar
• Dumortier H, Lacotte S, Pastorin G, Marega R, Wu W, Bonifazi D, Briand JP, Prato M, Muller S, Bianco A. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Lett 2006; 6: 1522–1528
   PubMed Web of Science ®Google Scholar
• Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, Macnee W, Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008; 3: 423–428
   PubMed Web of Science ®Google Scholar
• Ryman-Rasmussen JP, Cesta MF, Brody AR, Shipley-Phillips JK, Everitt JI, Tewksbury EW, Moss OR, Wong BA, Dodd DE, Andersen ME, et al. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol 2009; 4: 747–751
   PubMed Web of Science ®Google Scholar
• Liu Z, Cai W, He L, Nakayama N, Chen K, Sun X, Chen X, Dai H. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2007; 2: 47–52
   PubMed Web of Science ®Google Scholar
• Liu Z, Davis C, Cai W, He L, Chen X, Dai H. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci USA 2008; 105: 1410–1415
   PubMed Web of Science ®Google Scholar
• Schipper ML, Nakayama-Ratchford N, Davis CR, Kam NW, Chu P, Liu Z, Sun X, Dai H, Gambhir SS. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat Nanotechnol 2008; 3: 216–221
   PubMed Web of Science ®Google Scholar
• Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, Bianco A, Kostarelos K. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 2006; 103: 3357–3362
   PubMed Web of Science ®Google Scholar
• Kolosnjaj-Tabi J, Hartman KB, Boudjemaa S, Ananta JS, Morgant G, Szwarc H, Wilson LJ, Moussa F. In vivo behavior of large doses of ultrashort and full-length single-walled carbon nanotubes after oral and intraperitoneal administration to swiss mice. ACS Nano 2010;23:1481–1492.
   Google Scholar
• Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldofner N, Scholz R, Deger S, Wust P, Loening SA, Jordan A. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique. Int J Hyperthermia 2005; 21: 637–647
   PubMed Web of Science ®Google Scholar
• Gneveckow U, Jordan A, Scholz R, Bruss V, Waldofner N, Ricke J, Feussner A, Hildebrandt B, Rau B, Wust P. Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300 F for clinical magnetic fluid hyperthermia. Med Phys 2004; 31: 1444–1451
   PubMed Web of Science ®Google Scholar
• Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldofner N, Scholz R, Jung K, Jordan A, Wust P, Loening SA. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial. Int J Hyperthermia 2007; 23: 315–323
   PubMed Web of Science ®Google Scholar
• Salloum M, Ma RH, Weeks D, Zhu L. Controlling nanoparticle delivery in magnetic nanoparticle hyperthermia for cancer treatment: Experimental study in agarose gel. Int J Hyperthermia 2008; 24: 337–345
   PubMed Web of Science ®Google Scholar
• Salloum M, Ma R, Zhu L. Enhancement in treatment planning for magnetic nanoparticle hyperthermia: Optimization of the heat absorption pattern. Int J Hyperthermia 2009; 25: 309–321
   PubMed Web of Science ®Google Scholar
• Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV. Renal clearance of quantum dots. Nat Biotechnol 2007; 25: 1165–1170
   PubMed Web of Science ®Google Scholar
• Champion JA, Mitragotri S. Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 2009; 26: 244–249
   PubMed Web of Science ®Google Scholar
• Akiyama Y, Mori T, Katayama Y, Niidome T. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J Control Release 2009; 139: 81–84
   PubMed Web of Science ®Google Scholar
• Choi HS, Ipe BI, Misra P, Lee JH, Bawendi MG, Frangioni JV. Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots. Nano Lett 2009; 9: 2354–2359
   PubMed Web of Science ®Google Scholar
• Veronese FM. Peptide and protein PEGylation: A review of problems and solutions. Biomaterials 2001; 22: 405–417
   PubMed Web of Science ®Google Scholar
• Diagaradjane P, Orenstein-Cardona JM, Colon-Casasnovas NE, Deorukhkar A, Shentu S, Kuno N, Schwartz DL, Gelovani JG, Krishnan S. Imaging epidermal growth factor receptor expression in vivo: Pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin Cancer Res 2008; 14: 731–741
   PubMed Web of Science ®Google Scholar
• Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldofner N, Scholz R, Jordan A, Loening SA, Wust P. Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution. Eur Urol 2007; 52: 1653–1661
   PubMed Web of Science ®Google Scholar
• Zaman RT, Diagaradjane P, Wang J, Swartz J, Gill-Sharp K, Rajaram N, Payne DJ, Krishnan S, Tunnell JW. In vivo detection of gold nanoshells in tumors using diffuse optical spectroscopy. IEEE J Sel Top Quant Elec 2007; 13: 1715–1720
   PubMed Web of Science ®Google Scholar
• Puvanakrishnan P, Park J, Diagaradjane P, Schwartz JA, Coleman CL, Gill-Sharp KL, Sang KL, Payne JD, Krishnan S, Tunnell JW. Near-infrared narrow-band imaging of gold/silica nanoshells in tumors. J Biomed Opt 2009; 14: 024044
   PubMed Web of Science ®Google Scholar
• Bardhan R, Grady NK, Cole JR, Joshi A, Halas NJ. Fluorescence enhancement by Au nanostructures: Nanoshells and nanorods. ACS Nano 2009; 3: 744–752
   PubMed Web of Science ®Google Scholar
• Cheong SK, Jones BL, Siddiqi AK, Liu F, Manohar N, Cho SH. X-ray fluorescence computed tomography (XFCT) imaging of gold nanoparticle-loaded objects using 110 kVp x-rays. Phys Med Biol 2009; 55: 647–662
   Web of Science ®Google Scholar
• Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett 2007; 7: 1929–1934
   PubMed Web of Science ®Google Scholar
• Wu CF, Liang XP, Jiang HB. Metal nanoshells as a contrast agent in near-infrared diffuse optical tomography. Opt Commun 2005; 253: 214–221
   Web of Science ®Google Scholar
• Elliott A, Schwartz J, Wang J, Shetty A, Hazle J, Stafford JR. Analytical solution to heat equation with magnetic resonance experimental verification for nanoshell enhanced thermal therapy. Lasers Surg Med 2008; 40: 660–665
   PubMed Web of Science ®Google Scholar
• Cheong SK, Krishnan S, Cho SH. Modeling of plasmonic heating from individual gold nanoshells for near-infrared laser-induced thermal therapy. Med Phys 2009; 36: 4664–4671
   PubMed Web of Science ®Google Scholar
• Hurwitz M. Editorial: Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution. Eur Urol 2007; 52: 1661–1662
   PubMed Web of Science ®Google Scholar
• Wust P, Cho CH, Hildebrandt B, Gellermann J. Thermal monitoring: Invasive, minimal-invasive and non-invasive approaches. Int J Hyperthermia 2006; 22: 255–262
   PubMed Web of Science ®Google Scholar
• Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004; 22: 969–976
   PubMed Web of Science ®Google Scholar
• Rajasekaran AK, Anilkumar G, Christiansen JJ. Is prostate-specific membrane antigen a multifunctional protein?. Am J Physiol Cell Physiol 2005; 288: C975–981
   PubMed Web of Science ®Google Scholar
• Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 1997; 3: 81–85
   PubMed Web of Science ®Google Scholar
• Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002; 2: 91–100
   PubMed Web of Science ®Google Scholar
• Visaria RK, Griffin RJ, Williams BW, Ebbini ES, Paciotti GF, Song CW, Bischof JC. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery. Mol Cancer Ther 2006; 5: 1014–1020
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004; 49: N309–315
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol 2008; 60: 977–985
   PubMed Web of Science ®Google Scholar
• Cho SH. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: A preliminary Monte Carlo study. Phys Med Biol 2005; 50: N163–173
   PubMed Web of Science ®Google Scholar
• Cho SH, Jones BL, Krishnan S. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/X-ray sources. Phys Med Biol 2009; 54: 4889–4905
   PubMed Web of Science ®Google Scholar
• Roeske JC, Nunez L, Hoggarth M, Labay E, Weichselbaum RR. Characterization of the theorectical radiation dose enhancement from nanoparticles. Technol Cancer Res Treat 2007; 6: 395–401
   PubMed Web of Science ®Google Scholar